Triple
T33388602
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ofatumumab |
E854986
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | anti‑CD20 antibody |
C7047
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: anti‑CD20 antibody Context triple: [Ofatumumab, instanceOf, anti‑CD20 antibody]
-
A.
monoclonal antibody
chosen
A monoclonal antibody is a laboratory-produced molecule engineered to bind specifically to a single epitope on an antigen, enabling targeted detection or treatment of diseases.
-
B.
Bruton tyrosine kinase inhibitor
A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
-
C.
antineoplastic immunomodulating agent
An antineoplastic immunomodulating agent is a drug that treats cancer by modifying or enhancing the body’s immune response to recognize and destroy malignant cells.
-
D.
Janus kinase inhibitor
A Janus kinase inhibitor is a drug that selectively blocks Janus kinase (JAK) enzymes to modulate cytokine signaling and reduce inflammation or abnormal immune activity in various diseases.
-
E.
bortezomib-containing product
A bortezomib-containing product is any pharmaceutical formulation that includes bortezomib as an active ingredient, typically used for the treatment of multiple myeloma and certain lymphomas.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3496d54048190a1cb91fdd7caa6ea |
completed | April 30, 2026, 12:22 p.m. |
Created at: May 1, 2026, 1:35 a.m.